PRESS RELEASE
16 February 2016

BCLA meeting will examine cell therapy for corneal disease

Eye care practitioners will have the chance to learn more about the use of cell therapy in tackling corneal disease during the BCLA’s forthcoming evening meeting in London.

Alex Shortt will lead the meeting on Thursday, March 23, giving more information about his research from the past 10 years - which has focused on the development of cell therapies for corneal and conjunctival disease.

Alex has recently undertaken a prestigious four-year Wellcome Trust Clinician Scientist Award investigating the response of the recipient’s immune system to engrafted stem cells.

He said: “My goal is to improve the lives of patients with chronic, severe ocular surface disease through the delivery of novel cellular therapies using different therapeutic cell types.”

Delegates attending the evening meeting will, pending approval, receive one CET point.

The event will be held at The Royal College of Surgeons, London. Registration and a drinks reception will start at 6pm with the evening lecture getting underway at 7pm.

Entry is free for full BCLA members and are advised to register in advance here. Online registration for this event closes at midnight on Wednesday 22 March. For more details and to book your place visit www.bcla.org.uk

There are a limited number of VIP guest places available for this event. Email your full name, email, telephone and GOC number to [email protected] to book. Spaces available on first come, first served basis.


Notes to editors
• For interviews, call Daniel Owens from Orange Juice Communications on 07909 916668 or email [email protected]